• 文档语言：英文
• 文档大小：14KB
• 文档类型：PPT
• 发布时间：2017/6/9 14:45:08
• 相关网站：internet
• 下载
• 版权说明：本站所有资源来源于网络，版权为原作者所有，本站刊载，仅限于促进医药行业发展、科技进步之目的。如本站行为侵犯了您的合法权益，请来信告知，我们将妥善处理。给您带来不便，敬请原谅。
• 幻灯介绍：

PRISM-PLUS: Demographics of Patients With Diabetes
 Patients Without Patients With
 Diabetes Diabetes
 (n=1208) (n=362)
Mean age (y)  62   66
Prior MI  40%   47%
Heart failure  7%   16%
PTCA  31%   28%
CABG  23%   24%
PRISM-PLUS: MI/Death Outcomes in Patients With Diabetes
% Patients
9.3%
1.2%
P=0.004
15.5%
4.7%
P=0.002
19.2%
11.2%
P=0.044
Day 7
Day 30
Day 180
PRISM-PLUS: MI in Patients With Diabetes
% Patients
7.8%
0%
P<0.001
11.4%
1.8%
P=0.002
13.5%
4.7%
P=0.008
Day 7
Day 30
Day 180
PRISM-PLUS: Results in Patients With Diabetes
Conclusion
Tirofiban + heparin therapy resulted in a marked sustained reduction in major cardiac outcomes, particularly recurrent MI, in patients with diabetes presenting with UAP/NQWMI.